000 01165 a2200313 4500
005 20250517093131.0
264 0 _c20180101
008 201801s 0 0 eng d
022 _a1879-0852
024 7 _a10.1016/j.ejca.2016.03.065
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Jong, Roy G P J
245 0 0 _aComments on "Use of metformin and risk of kidney cancerĀ in patients with type 2 diabetes", Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c07 2016
300 _a157-8 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aDiabetes Mellitus, Type 2
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
650 0 4 _aKidney Neoplasms
650 0 4 _aMetformin
650 0 4 _aRisk
700 1 _aNielen, Johannes T H
700 1 _aMasclee, Ad A M
700 1 _aJanssen-Heijnen, Maryska L G
700 1 _ade Vries, Frank
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 61
_gp. 157-8
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2016.03.065
_zAvailable from publisher's website
999 _c25974761
_d25974761